StockData
Design Therapeutics, Inc. logo

Design Therapeutics, Inc. (DSGN) stock

DSGNNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 7/30
$9.84−0.08 (-0.81%)

Close on Nov 17, 2026Market cap $615.80MP/E –Yield –

Design Therapeutics price to book ratio

The price-to-book ratio is market cap divided by shareholders' equity.

Design Therapeutics's price to book ratio was 3.3× on Nov 11, 2026, against 2.7× a year earlier. Over the last 5 years it ranged from 0.4× to 4.7×, with a median of 1.5×.

Price to Book Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 20263.3×+0.7
2025Dec 31, 20252.7×+1.3
2024Dec 31, 20241.4×+0.9
2023Dec 29, 20230.5×−1.2
2022Dec 30, 20221.7×−1.3
2021Dec 31, 20213.0×–

More Design Therapeutics figures

See a number that looks wrong?